These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32565127)

  • 1. Comparison of Overall Survival Between De Novo and Secondary Acute Lymphoblastic Leukemia Patients of Different Ages.
    Zhong J; Yu X; Zhang X
    Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):e622-e627. PubMed ID: 32565127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis.
    Giri S; Chi M; Johnson B; McCormick D; Jamy O; Bhatt VR; Martin MG
    Leuk Res; 2015 Dec; 39(12):1342-6. PubMed ID: 26427729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes.
    Swaika A; Frank RD; Yang D; Finn LE; Jiang L; Advani P; Chanan-Khan AA; Ailawadhi S; Foran JM
    Cancer Med; 2018 Feb; 7(2):499-507. PubMed ID: 29282894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of secondary acute lymphoblastic leukemia with L3 morphology in adult patients.
    Petit B; Mele L; Rack K; Camera A; Vekemans MC; Bassan R; Pulsoni A; Delannoy A; Pagano L
    Leuk Lymphoma; 2002 Aug; 43(8):1599-604. PubMed ID: 12400602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    Wang J; Jiang Q; Xu LP; Zhang XH; Chen H; Qin YZ; Ruan GR; Jiang H; Jia JS; Zhao T; Liu KY; Jiang B; Huang XJ
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):741-750. PubMed ID: 29247779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of de novo and secondary acute promyelocytic leukemia: a propensity-matched analysis of the SEER database.
    Giri S; Pathak R; Martin MG; Bhatt VR
    Leuk Lymphoma; 2016 Feb; 57(2):385-391. PubMed ID: 26084205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to
    Aldoss I; Stiller T; Tsai NC; Song JY; Cao T; Bandara NA; Salhotra A; Khaled S; Aribi A; Al Malki MM; Mei M; Ali H; Spielberger R; O'Donnell M; Snyder D; Slavin T; Nakamura R; Stein AS; Forman SJ; Marcucci G; Pullarkat V
    Haematologica; 2018 Oct; 103(10):1662-1668. PubMed ID: 29903756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary Acute Leukemia in Sarcoma Patients: A Population-Based Study.
    Sanford NN; Martin AM; Brunner AM; Cote GM; Choy E; DeLaney TF; Aizer AA; Chen YL
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):687-694. PubMed ID: 29413281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.
    Atsuta Y; Suzuki R; Nagamura-Inoue T; Taniguchi S; Takahashi S; Kai S; Sakamaki H; Kouzai Y; Kasai M; Fukuda T; Azuma H; Takanashi M; Okamoto S; Tsuchida M; Kawa K; Morishima Y; Kodera Y; Kato S;
    Blood; 2009 Feb; 113(8):1631-8. PubMed ID: 19104080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term destiny of adolescents and young adults with de novo acute lymphoblastic leukemia treated with a pediatric protocol type].
    López-Hernández MA; Alvarado-Ibarra M; Álvarez-Veral JL; Ortiz-Zepeda M; Guajardo-Leal ML; Cota-Range X
    Gac Med Mex; 2016; 152(5):439-443. PubMed ID: 27792701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Area deprivation is associated with poorer overall survival in children with acute lymphoblastic leukemia.
    Schraw JM; Peckham-Gregory EC; Rabin KR; Scheurer ME; Lupo PJ; Oluyomi A
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28525. PubMed ID: 32573920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Less Intensive Chemotherapy and an Autotransplant Cure Adult T-Cell Acute Lymphoblastic Leukemia?
    Parovichnikova E; Troitskaya V; Sokolov A; Gavrilina O; Akhmerzaeva Z; Kuzmina L; Kliasova G; Chabaeva J; Kulikov S; Bondarenko S; Baranova O; Samoilova O; Kaplanov K; Minaeva N; Savchenko V;
    Acta Haematol; 2020; 143(2):131-139. PubMed ID: 31597157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.
    Ruggeri A; Labopin M; Sanz G; Piemontese S; Arcese W; Bacigalupo A; Blaise D; Bosi A; Huang H; Karakasis D; Koc Y; Michallet M; Picardi A; Sanz J; Santarone S; Sengelov H; Sierra J; Vincent L; Volt F; Nagler A; Gluckman E; Ciceri F; Rocha V; Mohty M; ;
    Leukemia; 2015 Sep; 29(9):1891-900. PubMed ID: 25882700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival disparities by age and country of diagnosis for patients with acute leukemia.
    Redaniel MT; Pulte D; Jeffreys M
    Leuk Lymphoma; 2015; 56(10):2787-92. PubMed ID: 25669926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia.
    Schmaelter AK; Labopin M; Socié G; Itälä-Remes M; Blaise D; Yakoub-Agha I; Forcade E; Cornelissen J; Ganser A; Beelen D; Labussière-Wallet H; Passweg J; Savani BN; Schmid C; Nagler A; Mohty M
    Blood Cancer J; 2020 Mar; 10(3):26. PubMed ID: 32127519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proportion of long-term event-free survivors and lifetime of adult patients not cured after a standard acute lymphoblastic leukemia therapeutic program: adult acute lymphoblastic leukemia-94 trial.
    Le QH; Thomas X; Ecochard R; Iwaz J; Lhéritier V; Michallet M; Fiere D
    Cancer; 2007 May; 109(10):2058-67. PubMed ID: 17407135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT.
    Piemontese S; Boumendil A; Labopin M; Schmid C; Ciceri F; Arcese W; Koc Y; Gulbas Z; Tischer J; Bruno B; Wu D; Blaise D; Beelen D; Irrera G; Ruggeri A; Houhou M; Mohty M; Nagler A;
    J Hematol Oncol; 2019 Jul; 12(1):68. PubMed ID: 31272508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential survival improvement for patients 20-29 years of age with acute lymphoblastic leukemia.
    Pole JD; Darmawikarta D; Alibhai SM; Brandwein JM; Sung L
    Leuk Res; 2013 Oct; 37(10):1258-64. PubMed ID: 23867057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding disparities in leukemia: a national study.
    Patel MI; Ma Y; Mitchell BS; Rhoads KF
    Cancer Causes Control; 2012 Nov; 23(11):1831-7. PubMed ID: 22971999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.
    Kantarjian HM; DeAngelo DJ; Stelljes M; Martinelli G; Liedtke M; Stock W; Gökbuget N; O'Brien S; Wang K; Wang T; Paccagnella ML; Sleight B; Vandendries E; Advani AS
    N Engl J Med; 2016 Aug; 375(8):740-53. PubMed ID: 27292104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.